Shield Therapeutics PLC (LSE:STX) - Share price - Overview

Stock Report

Shield Therapeutics PLC STX

Last Price
GBX167.50

Day Change
0.00|0.00%

As of 19/04/2017
16:36:43 BST | GBX
Minimum 15 Minutes Delay.

Last Close167.50p
Day Range167.00 - 167.00
Mkt Cap181.10Mil
52-Wk Range147.00 - 180.00
Yield %0.00
ISINGB00BYV81293
Volume2,800
P/E-11.17
P/SInfinity
P/CF-43.30

Share Price

Total Returns -

 Chg (%)  
More ...
Shield Therapeutics PLC- 
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.00-
Operating Profit-3.39-6.43-
Net Profit-13.43-24.49-
Reported EPS-12.00-22.00-
Balance Sheet
Current Assets0.562.33-
Non Current Assets0.450.53-
Total Assets1.002.86-
Current Liabilities9.003.58-
Total Liabilities19.2921.50-
Total Equity-18.28-18.64-
Cash Flow
Operating Cash Flow-3.34-4.18-
Net Change in Cash-1.070.25-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-19.00-16.10--10.40---
2018-7.40-5.97--28.06---

Company Profile

Shield Therapeutics PLC operates as a specialty pharmaceutical company specialising in the development and commercialisation of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

722 of 1850 Companies

Index

Outlook

(20/09/2016) no outlook statement

Next Event 30/06/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-12.8413.7915.90
Div Yld (E)0.003.894.29
PEG (E)0.000.320.96
ROCE0.00179.2018.09
Op Mrgn0.00-7.80-0.74
EPS Grwth0.0072.1428.10
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Andrew Heath
Chief Executive OfficerMr. Carl Sterritt
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.